|
|
|
Insider
Information: |
Sullivan Louis |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
195,903 |
|
Indirect Shares
|
20,185 |
|
|
Direct
Value |
$10,090,878 |
|
|
Indirect Value
|
$1,969,249 |
|
|
Total
Shares |
216,088 |
|
|
Total
Value |
$12,060,127 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
-4.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
Premium* |
|
3M Co |
MMM |
Director |
2006-05-09 |
1,722 |
2006-05-09 |
20,185 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2005-04-29 |
8,399 |
2004-04-23 |
0 |
Premium* |
|
Equifax Inc |
EFX |
Director |
2004-05-05 |
6,033 |
2004-05-05 |
0 |
Premium* |
|
Henry Schein Inc |
HSIC |
Director |
2016-03-04 |
14,096 |
2005-03-18 |
0 |
Premium* |
|
United Therapeutics Corp |
UTHR |
|
2024-05-03 |
13,060 |
2007-12-11 |
0 |
Premium* |
|
Emergent Biosolutions Inc. |
EBS |
Director |
2024-05-23 |
104,695 |
2010-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UTHR |
United Therapeutics Corp |
Director |
|
2010-10-29 |
4 |
AS |
$60.00 |
$336,000 |
D/D |
(5,600) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2011-01-03 |
4 |
AS |
$63.93 |
$383,591 |
D/D |
(6,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2011-03-01 |
4 |
AS |
$67.39 |
$404,331 |
D/D |
(6,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2011-05-02 |
4 |
AS |
$66.96 |
$401,760 |
D/D |
(6,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2014-05-22 |
4 |
AS |
$101.02 |
$3,043,828 |
D/D |
(30,000) |
0 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
|
|
2022-10-03 |
4 |
AS |
$211.56 |
$150,208 |
D/D |
(710) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-11-01 |
4 |
AS |
$230.28 |
$161,196 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2022-12-01 |
4 |
AS |
$279.89 |
$195,923 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-01-03 |
4 |
AS |
$276.26 |
$193,382 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-02-01 |
4 |
AS |
$261.33 |
$182,931 |
D/D |
(700) |
12,180 |
0 |
% |
|
UTHR |
United Therapeutics Corp |
|
|
2023-03-01 |
4 |
AS |
$245.10 |
$171,570 |
D/D |
(700) |
12,180 |
0 |
% |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2011-01-13 |
4 |
B |
$1.72 |
$17,200 |
D/D |
10,000 |
37,898 |
2.39 |
- |
|
ANIP |
ANI Pharmaceuticals Inc |
Director |
|
2011-08-15 |
4 |
B |
$2.67 |
$26,700 |
D/D |
10,000 |
47,898 |
2.39 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2004-04-23 |
4 |
D |
$24.80 |
$55,329 |
D/D |
(2,231) |
6,688 |
|
- |
|
EFX |
Equifax Inc |
Director |
|
2004-05-05 |
4 |
D |
$24.64 |
$72,713 |
D/D |
(2,951) |
6,033 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
Director |
|
2005-04-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,518) |
8,400 |
|
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2013-03-08 |
4 |
D |
$90.32 |
$121,571 |
D/D |
(1,346) |
20,987 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2015-03-09 |
4 |
D |
$138.97 |
$92,693 |
D/D |
(667) |
19,798 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2015-03-27 |
4 |
D |
$138.80 |
$54,132 |
D/D |
(390) |
19,408 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2015-06-18 |
4 |
D |
$185.78 |
$5,573,400 |
D/D |
(30,000) |
0 |
0 |
- |
|
HSIC |
Henry Schein Inc |
Director |
|
2016-03-02 |
4 |
D |
$168.93 |
$106,933 |
D/D |
(633) |
16,830 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-06-05 |
4 |
D |
$108.50 |
$1,627,500 |
D/D |
(15,000) |
1,750 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-07-02 |
4 |
D |
$113.81 |
$113,810 |
D/D |
(1,000) |
3,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-08-01 |
4 |
D |
$116.66 |
$116,660 |
D/D |
(1,000) |
3,370 |
0 |
- |
|
UTHR |
United Therapeutics Corp |
Director |
|
2018-09-04 |
4 |
D |
$119.45 |
$119,450 |
D/D |
(1,000) |
3,370 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|